Home › Immunoblastic Lymphadenopathy › Minnesota › Rochester
Immunoblastic Lymphadenopathy clinical trials in Rochester, MN
3 studies for Immunoblastic Lymphadenopathy are looking for participants at sites in and around Rochester (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
RecruitingPhase 2
- Mayo Clinic in Rochester, Rochester
A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
RecruitingPhase 1
- Mayo Clinic in Rochester, Rochester
A Registry for People With T-cell Lymphoma
RecruitingObservational study
- Mayo Clinic (Data Collection Only), Rochester
Immunoblastic Lymphadenopathy trials in other cities
- New York City, NY5 studies
- Durham, NC4 studies
- Houston, TX4 studies
- Miami, FL4 studies
- Chicago, IL4 studies
- St. Louis, MO3 studies
- Boston, MA3 studies
- Atlanta, GA3 studies
- Columbus, OH3 studies
- New Haven, CT3 studies
- Baldwin Park, CA3 studies
- Edison, NJ3 studies
Other studies in Rochester
- Breast Cancer42 studies
- Non-Small Cell Lung Cancer37 studies
- Cancer (all types)30 studies
- Metastatic Cancer30 studies
- Ovarian Cancer29 studies
- Colorectal Cancer29 studies
- Multiple Myeloma24 studies
- Pancreatic Cancer23 studies
- Heart Failure22 studies
- Prostate Cancer22 studies
- Lung Cancer20 studies
- Endometrial Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.